Publication:
CRISPR/Cas technology as a promising weapon to combat viral infections

Simple item page
dc.contributor.affiliationFundación IMDEA-Nanociencia, Madrid, Spain, Nanobiotecnología (IMDEA-Nanociencia), Unidad Asociada al Centro Nacional de Biotecnología (CSIC), Madrid, Spainen
dc.contributor.affiliation000000041762408X
dc.contributor.authorEscalona-Noguero C.
dc.contributor.authorLópez-Valls M.
dc.contributor.authorSot, Begoña
dc.date.accessioned2021-03-12T09:15:04Z
dc.date.available2021-03-12T09:15:04Z
dc.date.issued2021
dc.identifier.doi10.1002/bies.202000315en
dc.identifier.urihttp://hdl.handle.net/20.500.12614/2531
dc.journal.titleBioEssaysen
dc.language.isoenen
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.accessRightsopen accessen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.titleCRISPR/Cas technology as a promising weapon to combat viral infectionsen
dc.typeresearch articleen
dspace.entity.typePublication

Files

Collections

Publications